Orion announced that its product Nubeqa has become the company's largest product to date, with its financial significance expected to increase further. Based on scenario planning with partner Bayer, Orion estimates that the annual net sales of Nubeqa, comprising tablet sales to Bayer and royalties, have the potential to exceed 1 billion euros in the future. This projection is subject to various factors, including regulatory developments, market conditions, and product indications.
For 2026, Orion expects net sales to be in the range of 1.900 billion euros to 2.100 billion euros. Operating profit is estimated to be between 550 million euros and 750 million euros.
Orion said it will publish the basis for the outlook in the Financial Statement Release to be published on 12 February 2026.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.